Sam Altmanās Hospital Stay: AI Genius Vs. Semaglutide Junk Food
OpenAI CEO Sam Altman, who once claimed to try semaglutide 'before it was cool,' ended up in the hospitalāno details except it was serious enough to ditch discipline for junk food binges, saying 'I now do basically nothing.' Semaglutide, aka Ozempic and Wegovy, is the trendy GLP-1 drug causing weight loss and Silicon Valley hysteria. Elon Musk, Altman's X-trolling frenemy, also popped Wegovy for that 'fit, ripped, and healthy' look while gorging on Jack-in-the-Box. Altmanās health routine crashed during his high-octane life as a new dad, traveling AI diplomat, and longevity investment enthusiast. Despite 15-hour fasts and vegetarian protein shakes circa 2018, the guy craves chocolate chip cookies at 11:30 pmāclearly, AI canāt optimize cravings.
Share the Story
Trying semaglutide before it was cool sounds less like health and more like a celebrity audition for 'How To Hospitalize Your Appetite 101.' Meanwhile, Sam Altman just mastered doing nothing but eating junk food like itās an AI breakthrough.
Sam Altmanās diet journey: from 15-hour fasts to 11:30 pm cookie binges, because nothing says CEO productivity like crashing on semaglutide and living his best junk food life.
OpenAI CEO confession: hospital visit courtesy of semaglutide and now officially eating junk food like itās an R&D activity. Thatās one startup pivot no investor expected.
Source: Businessinsider | Published: 11/7/2025 | Author: Henry Chandonnet
More Articles in Health
TrumpRX: Medicareās New Weight Loss CokeāNow in Pill Form!
90-Year-Old Powerlifters Crush Age, Bones, and Expectations
Forty-Something Brits Take on Identical Triplets: Sleep, Who Needs It?
Pickleball Achilles: From Court Pop to Star-Powered Sobfest
Jennifer Anistonās 20-Minute Gym Magic Outsmarts Aging, Knee Surgeries, And Netflix Bingeing
